Nivolumab-induced thyrotoxicosis shows similarities to autoimmune thyroiditis (predominance of CD8+ T-cells), while also showing granulomas, destruction of thyroidal follicles and chronic thyroid lymphocytic inflammation, which are not present in autoimmune thyroiditis (71). Here, CD8A is linked to autoimmune thyroid disease.